• Funding round led by Nexus NeuroTech Ventures and Venture Investors Health Fund • New
Data show that the clinically-validated, FDA-authorized EarliPointTM Evaluation for autism can provide objective, standardized, quantitative
The second generation of EarliPoint™ Evaluation uses a tablet to aid clinicians in diagnosing and
First FDA-cleared tool to assist clinicians in diagnosing and assessing autism in children as young
EarliTec Diagnostics Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children as